Fifth Third Bancorp grew its position in shares of Morgan Stanley (NYSE:MS – Free Report) by 1.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,531,436 shares of the financial services provider’s stock after acquiring an additional 18,301 shares during the quarter. Morgan Stanley comprises about 0.8% of Fifth Third Bancorp’s investment portfolio, making the stock its 28th largest holding. Fifth Third Bancorp’s holdings in Morgan Stanley were worth $243,437,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Princeton Global Asset Management LLC boosted its stake in Morgan Stanley by 645.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 179 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 155 shares during the period. Greykasell Wealth Strategies Inc. boosted its position in shares of Morgan Stanley by 65.2% during the third quarter. Greykasell Wealth Strategies Inc. now owns 185 shares of the financial services provider’s stock worth $29,000 after buying an additional 73 shares during the period. WFA of San Diego LLC acquired a new position in shares of Morgan Stanley during the second quarter worth approximately $28,000. Family Legacy Financial Solutions LLC grew its holdings in Morgan Stanley by 91.9% in the 3rd quarter. Family Legacy Financial Solutions LLC now owns 213 shares of the financial services provider’s stock worth $34,000 after buying an additional 102 shares in the last quarter. Finally, Compass Financial Services Inc acquired a new stake in Morgan Stanley in the 2nd quarter valued at approximately $32,000. Institutional investors and hedge funds own 84.19% of the company’s stock.
Morgan Stanley Trading Up 2.0%
Shares of NYSE:MS opened at $171.40 on Monday. The company has a debt-to-equity ratio of 3.27, a quick ratio of 0.79 and a current ratio of 0.79. The stock has a market capitalization of $272.40 billion, a price-to-earnings ratio of 16.79, a PEG ratio of 1.38 and a beta of 1.20. Morgan Stanley has a 1-year low of $94.33 and a 1-year high of $192.68. The company has a 50 day moving average price of $180.86 and a 200 day moving average price of $165.27.
Morgan Stanley Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Friday, January 30th were paid a $1.00 dividend. The ex-dividend date of this dividend was Friday, January 30th. This represents a $4.00 dividend on an annualized basis and a yield of 2.3%. Morgan Stanley’s dividend payout ratio (DPR) is currently 39.18%.
Insider Activity
In other Morgan Stanley news, insider Charles A. Smith sold 8,500 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $182.08, for a total transaction of $1,547,680.00. Following the sale, the insider directly owned 119,128 shares of the company’s stock, valued at $21,690,826.24. The trade was a 6.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Andrew M. Saperstein sold 30,330 shares of Morgan Stanley stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $183.62, for a total value of $5,569,194.60. Following the transaction, the insider owned 280,481 shares in the company, valued at $51,501,921.22. This represents a 9.76% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 129,191 shares of company stock worth $23,736,506. 0.19% of the stock is owned by company insiders.
Morgan Stanley News Summary
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Michael Grimes’ return to Morgan Stanley is being framed as catalyzing a rebound in technology IPO activity — investors see this as potentially boosting MS’s investment banking fees and market positioning in the tech IPO cycle. Michael Grimes Return Puts Morgan Stanley At Center Of Tech IPO Cycle
- Positive Sentiment: Morgan Stanley Investment Management is reportedly exploring a ~$500M continuation vehicle for India healthcare assets — a sign the firm is leveraging its asset‑management platform to generate fee income and secondary-market activity. That bolsters the revenue mix beyond trading/IB. Morgan Stanley said to consider $500 million India fund, shifts some assets
- Positive Sentiment: Morgan Stanley Research is publishing bullish thematic work (private AVs, AI/semiconductors and “buy‑the‑dip” views on resilient software names) that supports expectations for advisory and sales flow into technology and infrastructure sectors where MS has coverage and syndication presence. That research momentum can lift investor sentiment. Private AV Startups are About to Take Over U.S. Streets
- Neutral Sentiment: Morgan Stanley research pieces (e.g., recommended AI‑chip names) and analyst notes highlighting buy opportunities in software/semiconductors help the firm’s visible franchise, but are indirect drivers of near‑term stock moves — they mainly influence flow into sectors MS covers. SNDK or QCOM: Morgan Stanley Picks One Top AI Semiconductor Stock to Buy
- Negative Sentiment: Offsetting the positives, reporting that CEO Ted Pick’s total pay rose ~32% to ~$45M draws governance and cost scrutiny — some investors interpret large executive pay increases as a potential negative for shareholder alignment and a near‑term headline risk. Morgan Stanley CEO Ted Pick’s pay rises 32% to $45 million
Analyst Upgrades and Downgrades
MS has been the subject of several recent analyst reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Morgan Stanley in a research note on Thursday, January 22nd. JPMorgan Chase & Co. upped their price objective on shares of Morgan Stanley from $157.00 to $162.00 and gave the stock a “neutral” rating in a report on Thursday, January 8th. Jefferies Financial Group boosted their price target on shares of Morgan Stanley from $186.00 to $212.00 and gave the stock a “buy” rating in a research report on Tuesday, January 6th. Zacks Research raised shares of Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Finally, Evercore ISI lowered shares of Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 5th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $185.93.
Read Our Latest Report on Morgan Stanley
Morgan Stanley Profile
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Featured Stories
- Five stocks we like better than Morgan Stanley
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Trump & Musk’s Secret Bet on Silver — Exposed
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
